Depletion of the activating ligand elicited proliferation arrest in ErbB3 activated ovarian cancer cell lines, whereas cell lines with high ErbB3 expression levels but no expression of the activating ligand did not show ErbB3 activation and were not sensitive to ErbB3 targeting7. This evidence concerns the gene ERBB3 and ovarian cancer.